Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Kemi Olugemo

Kemi Olugemo

individual
Ecosystem influencer

About

Kemi Olugemo, M.D., FAAN is a physician-scientist and biotech clinical-development executive. She served as Chief Medical Officer of Korro Bio from May 2024 until her resignation effective November 12, 2025, after earlier leadership roles at Ultragenyx, Laronde/Sail Bio, Ionis, and Parexel. Public 2026 profiles also list her as President of Clinical Development Consulting, LLC and part of Junevity's clinical/medical team.

Areas of interest

biotechclinical developmentrare diseaseneurologyRNA editingdrug developmenthealth equitylongevity